Our bodies’ natural disease-fighting capabilities just might lead to new cancer therapy strategies.
Immuno-oncology has emerged as an exciting area of personalized medicine because of its tremendous potential to harness the immune system to target and destroy cancer cells with few side effects, when targeted to the right tumor at the right time. Researchers are exploring the complex relationship between tumor cells and the immune system within the tumor microenvironment in order to discover new immuno-oncology targets and therapies.
Many different cell types contribute to tumor growth. Having the ability to phenotype cells while maintaining cellular spatial relationships and morphological context can provide valuable information for cancer research.
Our Phenoptics™ quantitative pathology research solutions enables you to better understand the role between immune and other cells in the tumor microenvironment – in situ, in intact FFPE tissue sections. With Phenoptics you can visualize, analyze, quantify, and phenotype cells leading to a better understanding of cancer mechanisms and stratification of cases for translational research.
For research purposes only. Not for use in diagnostic procedures.
The Vectra® Polaris™ Automated Quantitative Pathology ...
The Vectra® 3 automated quantitative pathology imaging system ac ...